Sherrill, Christina H.
High Point University
3 papers on CoChatORCID 0000-0003-1054-0644
Most cited papers
- Verified
High-Dose Once-Weekly Semaglutide: A New Option for Obesity Management
Bradley, C. L., McMillin, S. M., Hwang, A. Y., & Sherrill, C. H. (2022) · Annals of Pharmacotherapy
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 16
- Verified
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice
Bradley, C. L., McMillin, S. M., Hwang, A. Y., & Sherrill, C. H. (2023) · Annals of Pharmacotherapy
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 13
- Verified
The pursuit of optimal semaglutide dosing in type 2 diabetes continues
Sherrill, C. H., & Hwang, A. Y. (2023) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free